Company news
Fennec Pharmaceuticals Inc. news in 2022
Fennec Pharmaceuticals Inc.'s news releases, calls and decks from 2022, newest first.
Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States
October 16, 2022
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from Petrichor
September 25, 2022
Fennec Pharmaceuticals Announces FDA Approval of PEDMARK® (Sodium Thiosulfate Injection)
September 20, 2022
Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor
August 21, 2022
Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
July 31, 2022
Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022
Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK™
April 26, 2022
Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference
March 24, 2022
Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedmark™
March 23, 2022
Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business Update
February 27, 2022
Decks in 2022
- Investor Presentation (August 2022)
Investor deck · 31 slides · August 2022
- Investor Presentation (February 2022)
Investor deck · 31 slides · February 2022
- Investor Presentation (January 2022)
Investor deck · 31 slides · January 2022